Alpha Teknova, Inc. (NASDAQ:TKNO) CFO Acquires $49,999.28 in Stock

Alpha Teknova, Inc. (NASDAQ:TKNO) CFO Matthew Lowell acquired 40,322 shares of the stock in a transaction on Friday, July 12th. The shares were bought at an average price of $1.24 per share, for a total transaction of $49,999.28. Following the purchase, the chief financial officer now owns 128,376 shares in the company, valued at $159,186.24. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Alpha Teknova Price Performance

TKNO stock traded up $0.07 during mid-day trading on Tuesday, hitting $1.35. The stock had a trading volume of 110,760 shares, compared to its average volume of 23,324. The firm has a fifty day simple moving average of $1.61 and a 200 day simple moving average of $2.41. The firm has a market capitalization of $55.11 million, a P/E ratio of -1.29 and a beta of 0.34. The company has a current ratio of 5.52, a quick ratio of 3.92 and a debt-to-equity ratio of 0.16. Alpha Teknova, Inc. has a 52 week low of $1.16 and a 52 week high of $4.27.

Alpha Teknova (NASDAQ:TKNO) last posted its quarterly earnings results on Monday, May 13th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.04. Alpha Teknova had a negative net margin of 97.85% and a negative return on equity of 38.24%. The business had revenue of $9.29 million for the quarter, compared to analyst estimates of $7.80 million. During the same quarter last year, the business posted ($0.31) EPS. As a group, research analysts forecast that Alpha Teknova, Inc. will post -0.65 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, Stephens reissued an “overweight” rating and set a $5.00 target price on shares of Alpha Teknova in a report on Wednesday, July 10th.

Institutional Investors Weigh In On Alpha Teknova

Large investors have recently modified their holdings of the business. State Board of Administration of Florida Retirement System bought a new stake in shares of Alpha Teknova during the 1st quarter worth $35,000. Fielder Capital Group LLC acquired a new position in Alpha Teknova during the fourth quarter worth about $156,000. FourWorld Capital Management LLC acquired a new position in Alpha Teknova during the first quarter worth about $135,000. Redmile Group LLC lifted its holdings in shares of Alpha Teknova by 6.5% in the first quarter. Redmile Group LLC now owns 171,453 shares of the company’s stock worth $434,000 after acquiring an additional 10,448 shares during the last quarter. Finally, Conestoga Capital Advisors LLC boosted its stake in shares of Alpha Teknova by 4.1% in the 4th quarter. Conestoga Capital Advisors LLC now owns 247,529 shares of the company’s stock valued at $923,000 after purchasing an additional 9,800 shares in the last quarter. Institutional investors and hedge funds own 13.81% of the company’s stock.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.